Tradestie Institutional Equity Comparison Engine
OLB vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Overall Edge
ENSC Captures Institutional Edge (2โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while OLB counters with relative strength in Growth & Margin. Fundamentally, OLB trades at N/M Forward P/E with -73.3% operating margin (-43.6% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, OLB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENSC
OLB N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner
OLB
Op Margin -73.3% vs -281.3% ยท YoY -43.6% vs -15.1%
Momentum & Technical Winner
ENSC
1Y -87.4% vs -80.3% ยท 52W Pos 0% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OLB
NASDAQ
The OLB Group, Inc. Common Stock
Services-Business Services, Nec
$0.12
-4.33% 1D
Market Cap
$3.8M
1M Return
-63.26%
1Y Return
-87.36%
Forward P/E
N/M
Unified AI Score
48.6 / 100
HOLD
Tech 48.0
Fund 46.0
Flow 50.0
Mom 60.0
ENSC
NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap
$7.0M
1M Return
-29.55%
1Y Return
-80.33%
Forward P/E
0.8x
Unified AI Score
53.4 / 100
HOLD
Tech 50.0
Fund 62.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OLB -87.36%
ENSC -80.33%
Spread: +7.03 pp (ENSC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | OLB Revenue | ENSC Revenue | OLB Op. Margin | ENSC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $10M | N/A | 5.9% | N/A | OLB |
| FY2019 | $10M | N/A | -2.6% | N/A | OLB |
| FY2020 | $10M | $0M | -7.5% | -41.0% | OLB |
| FY2021 | $20M | $0M | -28.5% | -562.7% | OLB |
| FY2022 | $30M | $0M | -26.9% | -959.9% | OLB |
| FY2023 | $30M | $0M | -76.8% | -480.5% | OLB |
| FY2024 | $10M | $10M | -90.9% | -129.2% | OLB |
| FY2025 | $10M | $10M | -59.5% | -202.1% | OLB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OLB | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.8M | $7.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | -43.6% | -15.1% | Higher Growth | ENSC |
| Operating Margin (TTM) Profitability | -73.3% | -281.3% | Higher Margin | OLB |
| Net Profit Margin Profitability | -68.2% | -280.5% | Higher Margin | OLB |
| Return on Equity (ROE) Capital Efficiency | -70.8% | -1295.1% | Higher ROE | OLB |
| 52-Week Range Position Momentum | 0% ($0โ$2) | 8% ($0โ$2) | Stronger Trend | ENSC |
| Beta / 30D Volatility Risk Regime | 1.80ฮฒ ยท 120% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 48.6 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OLB vs ENSC Buy Guide
OLB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ENSC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OLB nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.